How well children tolerate and accept a new oral nutritional supplement
Official title: Acceptability (Including Gastrointestinal Tolerance, Compliance and Palatability) of a Paediatric Oral Nutritional Supplement Containing Food Blends.
Run by Société des Produits Nestlé (SPN) · NCT07210658 · Data updated 2026-11-12
This test tries a pediatric oral nutritional supplement in children aged 1–15 to see if they tolerate it, can take it as recommended, and like the taste.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Year to 16 Years |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | Société des Produits Nestlé (SPN) Industry-sponsored |
| Locations | 1 site (Nottingham) |
| Status | Recruiting |
| Started | April 14, 2025 |
| Main results expected | November 10, 2025 |
| Study ends | May 15, 2026 |
| Registry record updated | January 9, 2026 |
| Trial ID | NCT07210658 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are children aged 1–15 who already need one or more oral nutritional supplements to manage disease-related malnutrition and are stable on their current nutritional regimen.
✕Probably not a fit
Children with unsafe swallow, on total parenteral nutrition, with known food allergies, advanced CKD (stage G3b–G5), significant hepatic impairment, or suspected ileus/mechanical bowel obstruction are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Children who currently use an oral nutritional supplement and are stable on their regimen will replace their usual product with the investigational pediatric oral nutritional supplement and be followed for gastrointestinal tolerance, compliance, and palatability. Investigators will record intake adherence, collect caregiver- and patient-reported GI symptoms, and use short palatability questionnaires to rate taste and acceptability. Patients with unsafe swallow, significant kidney or liver impairment, ongoing total parenteral nutrition, known food allergies, or suspected bowel obstruction will be excluded. The study is sponsored by Société des Produits Nestlé and conducted at a Dietetics clinic in Nottingham.
Why it matters
Potential benefit: If successful, the product could provide a better-tolerated and more palatable oral supplement option to help children meet nutritional needs.
How similar studies have gone: Other acceptability and palatability studies of pediatric oral nutritional supplements have been performed previously and typically show product-specific, variable results rather than universal success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients from 1-15 years requiring 1 or more oral nutritional supplement to replace current oral nutritional supplement as part of their dietary management for disease related malnutrition. * Patients well-established and stable on current nutritional support regimen. * Willingly given, written, informed consent from patient/caregiver. Exclusion Criteria: * Unsafe swallow * Inability to comply with the study protocol, in the opinion of the investigator. * Under 1 years of age * Patients on total parenteral nutrition * Known food allergies, including any allergies to the ingredients * Patients with Chronic Kidney Disease (CKD) stage 3b (G3b), stage 4 (G4), stage 5 (G5) or hepatic impairment. * Participation in another interventional study within 2 weeks of this study. * Patients with known or suspected ileus or mechanical bowel obstruction
Where it's running
-
Dietetics
Nottingham, United Kingdom Recruiting
Study contacts
- Study coordinator: Sharan Saduera, BSc (Hons) Dietetics
- Email: sharan.saduera@uk.nestle.com
- Phone: +447557170649
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Paracetamol with ibuprofen versus paracetamol with metamizole for pain in children with acute pancreatitis
We will test whether IV paracetamol combined with ibuprofen or IV paracetamol combined with metamizole reduces pain more effectively in children aged 3–18 with acute pancreatitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.